Overview Aquestive is a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies. We are developing pharmaceutical products to deliver complex molecules through administrations that are alternatives to invasive and inconvenient standard of care therapies. We are advancing our late stage non-device based epinephrine prodrug product candidate for the treatment of severe allergic reactions, including anaphylax...
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-04 | 2025-12-31 | 0001398733-26-000018 | EDGAR | 90K words |
| 2025-03-05 | 2024-12-31 | 0001628280-25-010506 | EDGAR | — |
| 2024-03-05 | 2023-12-31 | 0001628280-24-009010 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0001628280-23-010180 | EDGAR | — |
| 2022-03-08 | 2021-12-31 | 0001628280-22-005393 | EDGAR | — |
| 2021-03-09 | 2020-12-31 | 0001140361-21-007811 | EDGAR | — |
| 2020-03-11 | 2019-12-31 | 0001140361-20-005499 | EDGAR | — |
| 2019-03-14 | 2018-12-31 | 0001140361-19-004934 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-30 | 0001398733-25-000028 | EDGAR | 39K words |
| 2025-08-11 | 2025-06-30 | 0001398733-25-000013 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001628280-25-024664 | EDGAR | — |
| 2024-11-04 | 2024-09-30 | 0001628280-24-045030 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0001628280-24-035225 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0001628280-24-021118 | EDGAR | — |
| 2023-11-06 | 2023-09-30 | 0001628280-23-037100 | EDGAR | — |
| 2023-08-07 | 2023-06-30 | 0001628280-23-027818 | EDGAR | — |
| 2023-05-02 | 2023-03-31 | 0001628280-23-014920 | EDGAR | — |
| 2022-11-01 | 2022-09-30 | 0001628280-22-027580 | EDGAR | — |
| 2022-08-02 | 2022-06-30 | 0001628280-22-020244 | EDGAR | — |
| 2022-05-04 | 2022-03-31 | 0001628280-22-012115 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-30 | 0001398733-26-000022 | EDGAR | 1K words |
| 2026-03-20 | 0001398733-26-000020 | EDGAR | — |
| 2026-03-04 | 0001398733-26-000016 | EDGAR | — |
| 2026-02-26 | 0001398733-26-000007 | EDGAR | — |
| 2026-02-02 | 0001398733-26-000005 | EDGAR | — |
| 2026-01-09 | 0001398733-26-000003 | EDGAR | — |
| 2025-11-06 | 0001398733-25-000030 | EDGAR | — |
| 2025-11-05 | 0001398733-25-000027 | EDGAR | — |
| 2025-10-08 | 0001398733-25-000022 | EDGAR | — |
| 2025-10-01 | 0001398733-25-000020 | EDGAR | — |
237 total filings indexed. 207 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001398733 |
| Ticker | AQST |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.aquestive.com |
| Listed | 2018-07-25 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report